| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1ddec7200bed351109e6d65a710f9f4c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_94c85f2ecd392272b5a8b7e2c795fe9b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 |
| filingDate |
2007-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe4041b696e29193d2e954c429bdb58f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d77014a3adeb8c2e96f12f56637f82e5 |
| publicationDate |
2010-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2010093621-A1 |
| titleOfInvention |
Scgb3a2 as a growth factor and anti-apoptotic agent |
| abstract |
The present disclosure is generally related to methods of using the secretory protein SCGB3A2 for promoting lung development and treating lung disease. Some embodiments are, for example, methods for treating and inhibiting the development of neonatal respiratory distress. Other embodiments are methods of promoting lung development in damaged or diseased lungs. Also disclosed are methods for inhibiting lung damage due to anti-cancer agents. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9797903-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11112403-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10408838-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3382391-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11333672-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11327071-B2 |
| priorityDate |
2006-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |